Ireland-based Mainstay Medical International said in a release it has begun selling and implanting its ReActiv8, an implantable restorative neurostimulation system that treats chronic low back pain, in Ireland.
ReActiv8 electrically stimulates the nerves responsible for contracting the key stabilizing muscles of the lumbar spine, Mainstay said. By activating these muscles, functional spine stability can be restored and help propel recovery from chronic low back pain, Mainstay said.
“ReActiv8 represents a novel approach to chronic low back pain which addresses the underlying cause of the condition,” Dr. Josh Keaveny, who helped in implanting the device, said in the release. “We now have a new option for treating patients who have suffered from debilitating back pain for years who are not candidates for spine surgery and have attempted many other conventional therapies without adequate relief.”
Keaveny and Dr. Alexander Moudrakovski impanted ReActive8 at St. Joseph’s Hospital, which is associated with the Beaumont Hospital Group, in Dublin.
“As part of our early commercialization strategy, we are building a network of reference sites in Europe, who can champion ReActiv8 and help expand the market,” Mainstay CEO Peter Crosby said in the release. “As an Irish company, Ireland is our home market, and we are pleased to partner with Dr. Keaveny and Dr. Moudrakovski to establish a foothold in our second European market following the start of commercialization in Germany.”